Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Unattributed | Alive

About Glialign

Glialign is a developer of a treatment for peripheral nerve damage spun out from University College London.

Glialign Headquarters Location

C/O John Sinden, Ucl Business, 97 Tottenham Court Road

London, England, W1T 4TP,

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Glialign News

UCL Technology Fund and UK Innovation & Science Seed Fund invest in Cell Therapy Company Glialign

May 25, 2018

The information provided by is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters here: Contact BioPortfolio . All rights reserved. All other trademarks recognized. Copyright © 1997-2018 BioPortfolio Limited. Site developed by Alacrify Ltd .

  • Where is Glialign's headquarters?

    Glialign's headquarters is located at C/O John Sinden, Ucl Business, 97, London.

  • What is Glialign's latest funding round?

    Glialign's latest funding round is Unattributed.

  • Who are the investors of Glialign?

    Investors of Glialign include Innovate UK, UK Innovation & Science Seed Fund and UCL Technology Fund.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.